LXEO

LXEO

Lexeo Therapeutics Inc. Common Stock

$4.090+-0.000 (-0.000%)

Reaalajas hind

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$4.090

Kõrge

$4.090

Madal

$4.090

Maht

0.11M

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Seotud uudised

GlobeNewswire

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

Cash runway extended into 2028; capital proceeds to fund operations through potential 2027 efficacy readout for LX2006 in Friedreich ataxia cardiomyopathy Financing led by Frazier Life Sciences and Janus Henderson

Vaata rohkem
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $15

HC Wainwright & Co. analyst Mitchell Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $23 to $15.

Vaata rohkem
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $15